Targeted Drug May Lower Odds for Breast Cancer’s Return in Some Patients
TUESDAY, June 6, 2023 (HealthDay News) — Here’s some good news for women with the most common type of breast cancer: Adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disea…
Learn MoreOpdivo Could Boost Outcomes for People Battling Hodgkin Lymphoma
TUESDAY, July 6, 2023 (HealthDay News) — The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard care is, new clin…
Learn MoreChinese Company May Help Ease U.S. Shortage of Cancer Drug
MONDAY, June 5, 2023 (HealthDay News) — With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.
The U.S. Food and Drug Administration is wor…
Chinese Company May Help Ease U.S. Shortage of Cancer Drug
MONDAY, June 5, 2023 (HealthDay News) — With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.The U.S. Food and Drug Administration is work…
Learn MoreChinese Company May Help Ease U.S. Shortage of Cancer Drug
MONDAY, June 5, 2023 (HealthDay News) — With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin.The U.S. Food and Drug Administration is work…
Learn MoreCapivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
MONDAY, June 5, 2023 (HealthDay News) — For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant therapy results in significantly longe…
Learn MoreCapivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
MONDAY, June 5, 2023 (HealthDay News) — For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase inhibitor, capivasertib-fulvestrant therapy results in significantly longe…
Learn MoreNew Drug Could Be Advance Against Glioma Brain Tumors
MONDAY, June 5, 2023 (HealthDay News) — An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progression-free survival in patient…
Learn MoreConsistent Breast Cancer Screening Cuts Odds of Dying From the Disease by 72%
MONDAY, June 5, 2023 (HealthDay News) — Screening mammograms saves lives, and consistency counts for a lot.That’s the main message from a new study that looked at how regularly women received mammograms before a breast cancer diagnosis. The closer a …
Learn More